




Searching News Database: chronic sinusitis
HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
HSMN NewsFeed - 25 Jul 2013
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
HSMN NewsFeed - 23 Sep 2011
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
HSMN NewsFeed - 23 Feb 2011
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
HSMN NewsFeed - 28 Apr 2010
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
HSMN NewsFeed - 4 May 2009
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
HSMN NewsFeed - 22 Sep 2008
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
HSMN NewsFeed - 16 Jul 2007
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
HSMN NewsFeed - 19 Sep 2006
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
HSMN NewsFeed - 12 Apr 2006
FDA Grants Accentia Biopharmaceuticals Fast Track Status for SinuNase(TM)
FDA Grants Accentia Biopharmaceuticals Fast Track Status for SinuNase(TM)
Additional items found! 6

Members Archive contains
6 additional stories matching:
chronic sinusitis
(Password required)
chronic sinusitis
(Password required)